Propaten Bioactive Surface
Payments companies reported to CMS as associated with Propaten Bioactive Surface. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Propaten Bioactive Surface, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Propaten Bioactive Surface
These are the largest totals companies reported as associated with Propaten Bioactive Surface. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| John Eidt | Dallas, TX | Vascular Surgery | $19,720.00 |
| Jeniann Yi | Aurora, CO | Vascular Surgery | $17,801.09 |
| Alan Lumsden | Houston, TX | Vascular Surgery | $16,530.00 |
| Marcus D'Ayala | Brooklyn, NY | Vascular Surgery | $284.07 |
| Matthew Foley | Portland, OR | Vascular Surgery | $194.62 |
| Carber Huang | Vancouver, WA | Vascular Surgery | $194.62 |
| Stephen Settle | Austin, TX | Vascular Surgery | $117.49 |
| Matthew Hendrich | Jonesboro, AR | Vascular Surgery | $51.33 |
| Charles Rigsbee | Jonesboro, AR | Nurse Anesthetist, Certified Registered | $51.31 |
| Hayavadhan Thuppal | Bronx, NY | Vascular Surgery | $38.75 |
Prescribed Propaten Bioactive Surface?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.